Lookup NU author(s): Dr Dipayan Mitra,
Professor Simon Bailey
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Effective treatment of children with medulloblastoma requires a functioning multi-disciplinary team with adequate neurosurgical, neuroradiological, pathological, radiotherapy and chemotherapy facilities and personnel. In addition the treating centre should have the capacity to effectively screen and manage any tumour and treatment-associated complications. These requirements have made it difficult for many low and middle-income countries (LMIC) centres to offer curative treatment. This article provides management recommendations for children with standard-risk medulloblastoma (localised tumours in children over the age of 3-5 years) according to the level of facilities available. Pediatr Blood Cancer 2015;62:553-564. (c) 2014 Wiley Periodicals, Inc.
Author(s): Parkes J, Hendricks M, Ssenyonga P, Mugamba J, Molyneux E, Schouten-van Meeteren A, Qaddoumi I, Fieggen G, Luna-Fineman S, Howard S, Mitra D, Bouffet E, Davidson A, Bailey S
Publication type: Article
Publication status: Published
Journal: Pediatric Blood & Cancer
Print publication date: 01/04/2015
Online publication date: 21/11/2014
Acceptance date: 16/09/2014
ISSN (print): 1545-5009
ISSN (electronic): 1545-5017
Publisher: John Wiley & Sons, Inc.
Altmetrics provided by Altmetric